Do we know all indications and side effects of sugammadex?;Connaissons-nous toutes les indications et tous les effets secondaires du sugammadex ?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 30, Issue 10, 2011, Pages 709-710

  Malinovsky, J M ^a   Plaud, B ^b   Debaene, B ^c   Mertes, P M ^d  

^a HÔPITAL MAISON BLANCHE   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Hypersensitive reaction; Obesity; Renal failure; Reversal agents; Sugammadex

Indexed keywords

SUGAMMADEX;

ADVERSE OUTCOME; EDITORIAL; TREATMENT INDICATION;

AGED; ANAPHYLAXIS; ANESTHESIA; BLOOD COAGULATION; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; HYDRONEPHROSIS; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; OBESITY;

EID: 80053941948     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2011.08.003     Document Type: Editorial

References (18)

1. Plaud B., Debaene B., Donati F., Marty J. Residual paralysis after emergence from anesthesia. Clinical concepts and commentary. Anesthesiology 2010, 112:1013-1022.
2. Debaene B., Meistelman C. Indications et utilisation clinique du sugammadex. Ann Fr Anesth Reanim 2009, 28(Suppl. 2):S57-S63.
3. Briere M., Boisson C., Cuvillon P., Debaene B., Ripart J. Sugammadex et insuffisance rénale: à propos d'un cas. Ann Fr Anesth Reanim 2011, 30. 10.1016/j.annfar.2011.02.010.
4. Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anesth 2011; Jul 13 [Epub ahead of print].
5. Staals L.M., Snoeck M.M.J., Driessen J.J., Flockton E.A., Heeringa M., Hunter J.M. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008, 101:492-497.
6. Staals L.M., Snoeck M.M.J., Driessen J.J., van Hamersvelt H.W., Flockton E.A., van den Heuvel M.W., et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010, 104:31-39.
7. Eleveld D.J., Kuizenga K., Proost J.H., Wierda J.M. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth Analg 2007, 104:582-584.
8. (dernier accès le 12 août 2011). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Product_Information/human/000885/WC500052310.pdf.
9. Raft J., Betala Belinga J.F., Jurkolow G., Desandes E., Longrois D., Meistelman C. Evaluation clinique du saignement post-chirurgical après injection de sugammadex. Ann Fr Anesth Reanim 2011, 30. 10.1016/j.annfar.2011.04.019.
10. McDonell N.J., Pavy T.J., Green L.K., Platt P.R. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011, 106:199-201.
11. Menendez-Ozcoidi L., Ortiz-Gomez J.R., Olaguibel-Ribero J.M., Salvador-Bravo M.J. Allergy to low dose sugammadex. Anaesthesia 2011, 66:217-219.
12. Jones P.M., Turkstra T.P. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010, 65:89-90.
13. Malinovsky J.M., Mazoit J.X., Sztark F., Estebe J.P., Capdevila X., Samii K., et al. Toxicité systémique des anesthésiques locaux et solutions lipidiques: une alternative supplémentaire intéressante. Ann Fr Anesth Reanim 2008, 27:132-134.
14. Sosis M.B. On the Withdrawal of Rapacuronium by the FDA. Anesth Patient Saf Found Newsl 2001, 16:30.
15. Goudsouzian N.G. Rapacuronium and bronchospasm. Anesthesiology 2001, 94:727-728.
16. Testa L., Bhindi R., Agostoni P., Abbate A., Zoccai G.G., van Gaal W.J. The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profile. Expert Opin Drug Saf 2007, 6:397-406.
17. Ray W.A., Stein C.M. The aprotinin story - is BART the final chapter?. N Engl J Med 2008, 358:2398-2400.
18. Psaty B.M., Furberg C.D. COX-2 inhibitors - lessons in drug safety. N Engl J Med 2005, 352:1133-1135.